BioSpace News Archive

Pharm Country

Avenue Therapeutics Receives Interim Response to its Formal Dispute Resolution Request from U.S. Food and Drug Administration Office of New Drugs

Avenue Therapeutics, Inc. today announced that it has received a written interim response from the Office of New Drugs (“OND”) of the U.S. Food and Drug Administration (“FDA”).

October 25, 2021
·
4 min read
Business

BrainStorm to Announce Third Quarter Financial Results and Provide a Corporate Update

BrainStorm Cell Therapeutics Inc. announced today that the Company will hold a conference call to update shareholders on financial results for the third quarter ended September 30, 2021 , and provide a corporate update, at 8:00 a.m. Eastern Time

October 25, 2021
·
3 min read
FDA

Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa in Combination With Pembrolizumab for the Treatment of Platinum-Resistant Ovarian Cancer

Alkermes plc today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to nemvaleukin alfa (nemvaleukin) for the treatment of platinum-resistant ovarian cancer.

October 25, 2021
·
5 min read
BioCapital

CASI Pharmaceuticals Announces Partner Juventas Completion Of Series C Financing Of $63 Million (RMB410 Million) For Acceleration Of CNCT19 Pivotal Trials And Commercialization

CASI Pharmaceuticals, Inc. today reported that Juventas Cell Therapy Ltd. (“Juventas”) has completed a Series C financing round through which it raised more than RMB410 million (approximately $63 million (USD)).

October 25, 2021
·
4 min read
Salix Will Feature New Data At The American College Of Gastroenterology® 2021 Annual Scientific Meeting

Research Findings for XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and RELISTOR® (methylnaltrexone bromide) Will be Presented

October 25, 2021
·
13 min read
Biotech Beach

Viking Therapeutics to Present Preclinical Data on Novel Dual GLP-1/GIP Agonists at ObesityWeek 2021

Viking Therapeutics, Inc. today announced that preclinical data from a series of novel dual agonists of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors will be presented at ObesityWeek 2021, the annual meeting of The Obesity Society.

October 25, 2021
·
4 min read
Business

Castle Biosciences to Release Third Quarter 2021 Financial Results and Host Conference Call on Monday, Nov. 8, 2021

Castle Biosciences, Inc. today announced that it will release its financial results for the third quarter and nine months ended Sept. 30, 2021, after the close of market on Monday, Nov. 8, 2021.

October 25, 2021
·
2 min read
Drug Development

Kiromic BioPharma, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01

Progression Free Survival of 7 months after Treatment with KiroVAX/BSK01 and Chemotherapy Versus 3.9 months with Standard of Care

October 25, 2021
·
7 min read
Lone Star Bio

Taysha Gene Therapies Announces Publication of Positive Proof-of-Concept Preclinical Data for an AAV-mediated UBE3A Gene Replacement

Taysha Gene Therapies Announces Publication of Positive Proof-of-Concept Preclinical Data for an AAV-mediated UBE3A Gene Replacement Approach Demonstrating Therapeutic Potential for The Treatment of Angelman Syndrome in the Journal JCI Insight

October 25, 2021
·
7 min read
EpiEndo Pharmaceuticals wins the Swedish American Life Sciences Summit (SALSS) Rising Star Award 2021

EpiEndo Pharmaceuticals ( www.epiendo.com ) is pleased to announce that it is the recipient of this year’s Rising Star Award at the Swedish American Life Sciences Summit (SALSS).

October 25, 2021
·
4 min read